Loading...
AMN Healthcare Services Inc is not a strong buy at this time for a beginner investor with a long-term strategy. The financial performance shows minimal growth, and technical indicators do not suggest a strong upward trend. While the long-term outlook for the sector is constructive, the near-term conditions remain uneven, and there are no significant positive trading signals or catalysts to justify immediate action.
The MACD is negative and contracting, RSI is neutral at 36.506, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot point of 18.625, with key support at 16.276 and resistance at 20.974. Overall, the technical indicators suggest a neutral to slightly bearish trend.

The company reported improved net loss figures in Q4 2025 compared to the previous year, and the healthcare staffing sector has a constructive long-term outlook with potential stabilization in 2026.
Q4 2025 financials showed a decline in EPS (-95.92% YoY) and gross margin (-12.00% YoY). The company missed EPS expectations, and there are no significant insider or hedge fund trading trends. Analysts have lowered the price target from $24 to $22, citing uneven near-term conditions.
In Q4 2025, revenue increased by 1.84% YoY to $748.2 million, but net income dropped to $0, and EPS fell by 95.92% YoY to -0.2. Gross margin also decreased by 12.00% YoY to 21.42%.
Analysts maintain an Outperform rating but have lowered the price target to $22 from $24, reflecting cautious optimism for the long-term outlook but acknowledging near-term challenges.